Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

Intelligence powered by the Humanexa engine.

Therapeutic Area

Antitussive

Therapeutic area intelligence for Antitussive with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.

Companies

RegulatoryJuly 27, 2026

The FDA has approved Aurobindo Pharma's application for Dextromethorphan Polistirex under ANDA218417.

No catalysts indexed for this entity yet.

No related entities indexed yet.

Newsletter

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.